February 8th, 2022 Coherent Market Insights Releases
Enrofloxacin (ENR) is a fluoroquinolone antibiotic that is used in veterinary medicine. The Bayer Corporation sells it under the brand name Baytril. The US Food and Drug Administration has licensed ENR for the treatment of individual pets and domestic animals in the United States. Pseudomonas aeruginosa, Klebsiella, and E.coli are just a few of the gram-positive and gram-negative bacteria that ENR may kill. It is used to treat skin and soft tissue infections, urinary tract infections in dogs and cats, Chlamydophila felis infections in cats, and Escherichia coli ulcerative colitis in dogs. Over the projected period, significant increase in the poultry industry is likely to have a beneficial influence on enrofloxacin market growth.
The global enrofloxacin market size is expected to witness potential gains in the future, and register a significant CAGR over the forecast period (2019 – 2027).
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ @ https://www.coherentmarketinsights.com/insight/request-pdf/2742
Increasing trend of adopting pets and using ENR in treatment of infections caused by both Gram-negative and Gram-positive bacteria are expected to propel the growth in the global enrofloxacin market growth. Cattle get ENR by a subcutaneous injection, while pigs get it through an intramuscular injection. It is usually given to cattle, pigs, turkeys, and chickens for the treatment of respiratory and gastrointestinal illnesses.
Increasing side effects and allergies of ENR such as diarrhea, lack of appetite and vomiting are expected to hamper the growth of enrofloxacin market. For instance, Enrofloxacin was phased out of usage in poultry farms in the United States in September 2005. Unfortunately, ENR usage in cats has been connected to retinal toxicity in a few cases.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/2742
Asia Pacific is expected to witness robust growth ย in the global enrofloxacin market, owning to increasing population and high demand for poultry meat in the region. Furthermore, China is expected to witness to augmented growth in the global enrofloxacin market, increasing prevalence pet industry in this region
Market ย players active in the global enrofloxacin market are KRKA d.d., Bayer Corporation, ย Pro Zoon, Novo mesto, VetMedic, VM Pharma and Chanelle Pharmaceuticals.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/2742
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: sales@coherentmarketinsights.com United States of America: +1-206-701-6702 United Kingdom: +44-020-8133-4027 Japan: +050-5539-1737 India: +91-848-285-0837
Sign up and submit a press release
Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.